Literature DB >> 10558853

Hepatocyte growth factor in human osteoarthritic cartilage.

D Pfander1, T Cramer, G Weseloh, O Pullig, D Schuppan, M Bauer, B Swoboda.   

Abstract

OBJECTIVE: Hepatocyte growth factor/scatter factor is a potent mitogen, morphogen and motogen for a variety of mainly epithelial cells. Hepatocyte growth factor is synthesized by mesenchymal cells and can be found in various tissues. The objective of this study was to investigate the expression and distribution patterns of this pleiotropic growth factor and its receptor, the product of the proto-oncogene c-met in normal and osteoarthritic human knee cartilage.
METHODS: Five normal and 14 osteoarthritic human cartilage samples graded histomorphologically by Mankin Score, were studied by radioactive in-situ hybridization and immunohistochemistry for the expression of Hepatocyte growth factor and the c-met receptor.
RESULTS: Hepatocyte growth factor could be found by immunohistochemistry in the territorial matrix surrounding the chondrocytes of calcified cartilage and within the deep zone of normal cartilage. Chondrocytes of these cartilage zones showed also positive c-met receptor-staining. Moreover, a small number of chondrocytes in the superficial and intermediate zone showed c-met staining. In accordance with the increased hepatocyte growth factor staining of osteoarthritic cartilage, an enhanced expression of hepatocyte growth factor-RNA by chondrocytes of the deep zone as well as the deeper mid zone was observed. Contrary to normal cartilage, c-met was identified immunohistochemically in osteoarthritic chondrocytes of all cartilage zones.
CONCLUSION: These results indicate that hepatocyte growth factor seems to be acting in an autocrine/paracrine manner in normal and osteoarthritic cartilage. The ubiquitous presence of the HGF/HGF-receptor complex in osteoarthritic chondrocytes suggests that hepatocyte growth factor may contribute to the altered metabolism in osteoarthritic cartilage. Copyright 1999 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10558853     DOI: 10.1053/joca.1999.0259

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  11 in total

1.  Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage.

Authors:  D Pfander; T Cramer; D Deuerling; G Weseloh; B Swoboda
Journal:  Ann Rheum Dis       Date:  2000-06       Impact factor: 19.103

2.  Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels.

Authors:  Claudia Grimmer; Nadine Balbus; Ute Lang; Thomas Aigner; Thorsten Cramer; Lutz Müller; Bernd Swoboda; David Pfander
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

3.  Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis.

Authors:  Beatriz Caramés; Noboru Taniguchi; Shuhei Otsuki; Francisco J Blanco; Martin Lotz
Journal:  Arthritis Rheum       Date:  2010-03

Review 4.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

5.  Aging-related loss of the chromatin protein HMGB2 in articular cartilage is linked to reduced cellularity and osteoarthritis.

Authors:  Noboru Taniguchi; Beatriz Caramés; Lorenza Ronfani; Ulrich Ulmer; Setsuro Komiya; Marco E Bianchi; Martin Lotz
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-12       Impact factor: 11.205

6.  Expression of the VEGF receptor-3 in osteoarthritic chondrocytes: stimulation by interleukin-1 beta and association with beta 1-integrins.

Authors:  M Shakibaei; G Schulze-Tanzil; A Mobasheri; T Beichler; J Dressler; W Schwab
Journal:  Histochem Cell Biol       Date:  2003-08-02       Impact factor: 4.304

7.  Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo.

Authors:  Marie-Therese Haider; Keith D Hunter; Simon P Robinson; Timothy J Graham; Eva Corey; T Neil Dear; Russell Hughes; Nicola J Brown; Ingunn Holen
Journal:  Bone       Date:  2015-08-14       Impact factor: 4.398

8.  Hepatocyte growth factor increases vascular endothelial growth factor-A production in human synovial fibroblasts through c-Met receptor pathway.

Authors:  Yu-Min Lin; Yuan-Li Huang; Yi-Chin Fong; Chun-Hao Tsai; Ming-Chih Chou; Chih-Hsin Tang
Journal:  PLoS One       Date:  2012-11-28       Impact factor: 3.240

Review 9.  The Potential Role of Hepatocyte Growth Factor in Degenerative Disorders of the Synovial Joint and Spine.

Authors:  Hitoshi Tonomura; Masateru Nagae; Ryota Takatori; Hidenobu Ishibashi; Tomonori Itsuji; Kenji Takahashi
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

Review 10.  Macro, Micro, and Molecular. Changes of the Osteochondral Interface in Osteoarthritis Development.

Authors:  Xiwei Fan; Xiaoxin Wu; Ross Crawford; Yin Xiao; Indira Prasadam
Journal:  Front Cell Dev Biol       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.